Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression | |
Wu, QL; Fu, YF; Zhou, WL; Wang, JX; Feng, YH; Liu, J; Xu, JY; He, PL; Zhou, R; Tang, W | |
刊名 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS |
2005-05 | |
卷号 | 313期号:2页码:705-711 |
ISSN号 | 0022-3565 |
DOI | 10.1124/jpet.104.080416 |
文献子类 | Article |
英文摘要 | Lymphocytes depend on transmethylation reactions for efficient activation and function. These reactions are primarily catalyzed by S-adenosylmethionine- dependent methyltransferases, which convert S-adenosylmethionine to S-adenosyl-L-homocysteine. S- adenosyl-L-homocysteine is then hydrolyzed by S- adenosyl-L-homocysteine hydrolase to prevent feedback inhibition of transmethylation reactions. By impeding S- adenosyl-L- homocysteine hydrolase, a build-up of S- adenosyl-L- homocysteine occurs, and most intracellular transmethylation reactions cease. Thus, a nontoxic inhibitor of this enzyme might be a useful immunosuppressive therapeutic agent. We identified a potent reversible type III inhibitor of S-adenosyl-L-homocysteine hydrolase, DZ2002 [ methyl 4-(adenin-9-yl)-2-hydroxybutanoate], and determined its cytotoxic and immunologic effects. We demonstrated that DZ2002 blocked S- adenosyl-L-homocysteine hydrolase more effectively than a type I inhibitor, but cytotoxicity from DZ2002 was greatly reduced. Although DZ2002 did not prevent concanavalin A-induced T cell proliferation or interleukin ( IL)-2 production, it significantly reduced both a mixed lymphocyte reaction and IL-12 production from in vitro-stimulated splenocytes. In addition, levels of CD80 and CD86 on human monocytic THP-1 cells were decreased in a dose-dependent manner in the presence of 0.1 to 10 mu M DZ2002, and decreases were also seen in IL-12 and tumor necrosis factor-alpha production from both mouse thioglycollate-stimulated peritoneal macrophages and THP-1 cells. In vivo, DZ2002 significantly suppressed a delayed-type hypersensitivity reaction as well as antibody secretion. We conclude that DZ2002' s immunosuppressive effects are likely not solely attributed to T cell inhibition but also to the obstruction of macrophage activation and function through reductions in cytokine output and/or T cell costimulation. These data suggest an important dual role for the S-adenosyl-L-homocysteine hydrolase in both macrophage and T cell function. |
WOS关键词 | DIFFERENTIAL REGULATION ; INDUCED ARTHRITIS ; INTERFERON-GAMMA ; IFN-GAMMA ; IN-VITRO ; CELLS ; INTERLEUKIN-12 ; PROLIFERATION ; MACROPHAGES ; ADENOSYLHOMOCYSTEINE |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS |
WOS记录号 | WOS:000228357900026 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/273881] |
专题 | 药理学第一研究室 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
通讯作者 | Zuo, JP |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, State Key Lab Drug Res, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Lab Immunopharmacol, Shanghai 201203, Peoples R China 3.Gen Atom Co, Diazyme Labs Div, San Diego, CA USA |
推荐引用方式 GB/T 7714 | Wu, QL,Fu, YF,Zhou, WL,et al. Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,2005,313(2):705-711. |
APA | Wu, QL.,Fu, YF.,Zhou, WL.,Wang, JX.,Feng, YH.,...&Zuo, JP.(2005).Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,313(2),705-711. |
MLA | Wu, QL,et al."Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression".JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 313.2(2005):705-711. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论